D. Goletti (Roma, Italy), J-P. Zellweger (Fribourg, Switzerland)
Performance of IFN-γ release assays for tuberculosis detection in immune-compromised children in a low prevalence country
M. Bocchino, E. Bruzzese, A. Matarese, L. Assante, M. Alessio, B. Bellofiore, A. Guarino, A. Sanduzzi (Naples, Italy)
|  |
Predictive value of a whole-blood IGRA for the development of active TB disease
R. Diel, R. Loddenkemper, A. Nienhaus (Duesseldorf, Berlin, Hamburg, Germany)
|  |
Clinical utility of the quantiFERON TB-2G test for elderly patients with active tuberculosis
Y. Kobashi, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki city, Japan)
| |
Discordance between T-cell-based assay and tuberculin skin testing among nursing students in India
D. J. Christopher, P. Daley, L. Armstrong, P. James, B. Premkumar, J. Sarojini Michael, M. Pai (Vellore/Tamil Nadu, India; Montreal/PQ, Canada)
|  |
IFN γ tests for tuberculosis – false positives with other T cell disease processes?
J. Robson, N. Coulson, N. Haley, J. Anderson, H. Hosker (Keighley, West Yorkshire, United Kingdom)
| |
Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals
L. Leidl, H. Mayanja-Kizza, J. Baseke, C. Hirsch, D. Goletti, Z. Toossi, C. Lange (Borstel, Germany; Kampala, Uganda; Cleveland, OH, United States Of America; Rome, Italy)
| |
Comparison of PPD and quantiferon tests in determining latent tuberculosis in patients who are directed to TNF antagonists
T. Cagatay, M. Aydin, Z. Gulbaran, R. Yildiz, L. Pur, A. Gul, M. Inanc, S. Kamali, K. Koksalan, B. Kiran, Z. Kilicaslan (Istanbul, Turkey)
| |
An assay based on RD1 selected peptides for the diagnosis of extra-pulmonary and smear negative tuberculosis
S. Carrara, O. Butera, V. Vanini, F. Palmieri, E. Girardi, D. Goletti (Rome, Italy)
| |